Mustang Bio
MBIO
92 hedge funds and large institutions have $85.7M invested in Mustang Bio in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 15 closing their positions.
122% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 18
108% more call options, than puts
Call options by funds: $1.95M | Put options by funds: $938K
7% more capital invested
Capital invested by funds: $80.5M → $85.7M (+$5.25M)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
3% less funds holding
Funds holding: 95 → 92 (-3)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.94M |
| 2 |
BlackRock
New York
|
+$3.12M |
| 3 |
Two Sigma Advisers
New York
|
+$2.66M |
| 4 |
Two Sigma Investments
New York
|
+$2.59M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.2M |
| 2 |
Renaissance Technologies
New York
|
-$2.57M |
| 3 |
Millennium Management
New York
|
-$2M |
| 4 |
JP Morgan Chase
New York
|
-$1.88M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.42M |
MBIO Hedge Fund Activity: Q2 2021 in Review
92 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2021, worth a combined $85.7M — up 6.5% from $80.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of MBIO and 12 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 40 added.
The largest buyer was Vanguard Group, adding an estimated $4.94M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $3.2M.
- 92 institutional investors held Mustang Bio (MBIO) as of Q2 2021, down from 95 in Q1 2021.
- Funds reported $85.7M of Mustang Bio stock for Q2 2021, up 6.5% quarter-over-quarter.
- 12 funds opened new Mustang Bio positions in Q2 2021 and 15 closed out, a net change of -3 holders.
- The largest Mustang Bio buyer in Q2 2021 was Vanguard Group, an estimated $4.94M added.
- The largest Mustang Bio seller in Q2 2021 was Jacobs Levy Equity Management, an estimated $3.2M sold.
Based on aggregated 13F filings for Q2 2021.